Last reviewed · How we verify

NCT07258134

Compare Stoma Reversal Wound Outcomes Between NPWT and Secondary Intention Healing

Completed NA Last updated 2 December 2025
What this trial tests

NA trial testing Negative Pressure Wound Therapy in Negative-Pressure Wound Therapy in 72 participants. Completed in 30 August 2025.

Timeline
24 February 2025
Primary endpoint
30 August 2025
30 August 2025

Quick facts

Lead sponsorSindh Institute of Urology and Transplantation
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment72
Start date24 February 2025
Primary completion30 August 2025
Estimated completion30 August 2025
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Sindh Institute of Urology and Transplantation

Who can join

Adults 18 to 80, any sex, with Negative-Pressure Wound Therapy or Wound Heal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This was a single-center, parallel-group randomized controlled trial conducted in 2024 at the General Surgery Ward of the Sindh Institute of Urology and Transplantation (SIUT), Karachi. The study compared negative pressure wound therapy (NPWT) with healing by secondary intention (SIH) for patients undergoing stoma reversal surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Negative Pressure Wound Therapy

Trials testing the same drug.

Other Sindh Institute of Urology and Transplantation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07258134.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing